U.S. Markets open in 8 hrs 20 mins

Bio-Rad Laboratories, Inc. (BIO)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
217.77-2.59 (-1.18%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,068,1722,019,4412,175,044
Cost of Revenue930,085897,771996,527
Gross Profit1,138,0871,121,6701,178,517
Operating Expenses
Research Development205,864192,972220,333
Selling General and Administrative816,724761,990808,200
Non Recurring62,30562,30562,305
Total Operating Expenses---
Operating Income or Loss53,194166,708149,984
Income from Continuing Operations
Total Other Income/Expenses Net10,3088313,704
Earnings Before Interest and Taxes63,502167,539153,688
Interest Expense21,94221,69222,131
Income Before Tax41,560145,847131,557
Income Tax Expense13,43532,75442,712
Minority Interest---
Net Income From Continuing Ops28,125113,09388,845
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income28,125113,09388,845
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares28,125113,09388,845